Angiocidal Effect of Cyclosporine in Cancer Therapy
环孢素在癌症治疗中的杀血管作用
基本信息
- 批准号:6873533
- 负责人:
- 金额:$ 13.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-14 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Our application represents a cross fertilization between oncology and transplantation by utilizing cyclosporin A (CyA) as an antiangiogenic agent in the treatment of cancers. Antiangiogenic agents are promising adjuncts in cancer therapy, but their potential has not been fully realized, partly due to a lack of a strong angiocidal effect of these drugs.
Our preliminary data in a mouse model of angiogenesis indicates that CyA has angiocidal effects, suggesting that CyA could be a potential antiangiogenic agent in cancer therapy. Our data also indicates that the toxicity of high dose CyA, at which the drug is angiocidal, is principally due to an excess release of Endothelin-1 (ET-1) and is prevented by blockade of the ET-1A receptor on smooth muscle and myocardial cells.
Our hypothesis is that high dose CyA will disrupt angiogenesis in tumors due to increase in endothelial cell oxidative stress leading to redistribution of VE-cadherin and loss of endothelial cell-cell contacts. We propose to test this hypothesis in a sarcoma xenograft model and a melanoma isograft model of cancer in mice by administering high dose CyA alone and in combination with a conventional chemotherapeutic agent. Tumor growth, angiogenesis, and drug toxicity will be monitored in these mice to determine if CyA synergizes with the chemotherapeutic agent in the treatment of cancer.
Our studies have the potential of discovering a novel, angiocidal effect of a commonly used drug. If successful, these studies will be translated expeditiously into clinical trials for the treatment of cancer.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DILIP S KITTUR其他文献
DILIP S KITTUR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DILIP S KITTUR', 18)}}的其他基金
Angiocidal Effect of Cyclosporine in Cancer Therapy
环孢素在癌症治疗中的杀血管作用
- 批准号:
7031611 - 财政年份:2005
- 资助金额:
$ 13.07万 - 项目类别:
MHC CLASS II INDUCTION IN ALLOGRAFT REJECTION
同种异体移植排斥中的 MHC II 类诱导
- 批准号:
3454463 - 财政年份:1989
- 资助金额:
$ 13.07万 - 项目类别:
MHC CLASS II INDUCTION IN ALLOGRAFT REJECTION
同种异体移植排斥中的 MHC II 类诱导
- 批准号:
3454460 - 财政年份:1989
- 资助金额:
$ 13.07万 - 项目类别:
MHC CLASS II INDUCTION IN ALLOGRAFT REJECTION
同种异体移植排斥中的 MHC II 类诱导
- 批准号:
3454462 - 财政年份:1989
- 资助金额:
$ 13.07万 - 项目类别:
MHC CLASS II INDUCTION IN ALLOGRAFT REJECTION
同种异体移植排斥中的 MHC II 类诱导
- 批准号:
3454461 - 财政年份:1989
- 资助金额:
$ 13.07万 - 项目类别:
MHC CLASS II INDUCTION IN ALLOGRAFT REJECTION
同种异体移植排斥中的 MHC II 类诱导
- 批准号:
3454464 - 财政年份:1989
- 资助金额:
$ 13.07万 - 项目类别:
相似海外基金
Tacrolimus and Plasmapheresis in Treatment-Resistant FSGS
他克莫司和血浆置换治疗难治性 FSGS
- 批准号:
7176978 - 财政年份:2006
- 资助金额:
$ 13.07万 - 项目类别:
RELATIVE VARIABILITY OF PROGRAF, NEORAL & CELLCEPT IN DIABETIC KIDNEY TXT PTS
PROGRAF、NEORAL 的相对变化
- 批准号:
7376540 - 财政年份:2006
- 资助金额:
$ 13.07万 - 项目类别:
IMMUNOTHERAPY TRIAL FOR NEW ONSET TYPE 1 DIABETES
新发 1 型糖尿病的免疫治疗试验
- 批准号:
7374331 - 财政年份:2006
- 资助金额:
$ 13.07万 - 项目类别:
Pharmacogenetics of Immune Suppressants in Kidney Transplantation
肾移植中免疫抑制剂的药物遗传学
- 批准号:
7148474 - 财政年份:2006
- 资助金额:
$ 13.07万 - 项目类别:
Therapeutic immunosuppression,inflammation & skin cancer
治疗性免疫抑制、炎症
- 批准号:
6925674 - 财政年份:2005
- 资助金额:
$ 13.07万 - 项目类别:
Therapeutic immunosuppression,inflammation & skin cancer
治疗性免疫抑制、炎症
- 批准号:
7048461 - 财政年份:2005
- 资助金额:
$ 13.07万 - 项目类别:
Anti-metastatic Effect of MCIP1 in Thyroid Cancer
MCIP1在甲状腺癌中的抗转移作用
- 批准号:
6851247 - 财政年份:2005
- 资助金额:
$ 13.07万 - 项目类别:
Hemorrhagic Brain Injury Repair with Human Cord Blood
用人脐带血修复出血性脑损伤
- 批准号:
6992921 - 财政年份:2005
- 资助金额:
$ 13.07万 - 项目类别: